Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
作者信息
Almeida J G, Christian M, Chacko C J, Taylor P M, Fritschi E P
出版信息
Lepr Rev. 1983 Sep;54(3):185-91. doi: 10.5935/0305-7518.19830025.
PMID:6355722
Abstract
摘要
相似文献
1
Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.卡里吉里施菲林麻风病研究与培训中心麻风病防治区古迪亚瑟姆镇麻风病患者中耐氨苯砜麻风分枝杆菌的研究。2. 进展报告。
Lepr Rev. 1983 Sep;54(3):185-91. doi: 10.5935/0305-7518.19830025.
2
Dapsone-resistant leprosy in Burundi.布隆迪的耐氨苯砜麻风病。
Lepr Rev. 1983 Sep;54(3):239-42. doi: 10.5935/0305-7518.19830031.
3
Secondary dapsone-resistant leprosy in Shanghai Municipality.上海市继发性氨苯砜耐药麻风病
Lepr Rev. 1983 Sep;54(3):197-202.
4
Dapsone-resistant leprosy and its implications for leprosy control programmes.耐氨苯砜麻风病及其对麻风病控制规划的影响。
Lepr Rev. 1977 Jun;48(2):83-94. doi: 10.5935/0305-7518.19770010.
5
Dapsone-resistant leprosy in Jakarta: a preliminary report.雅加达耐氨苯砜麻风病：初步报告。
Lepr Rev. 1983 Sep;54(3):193-5. doi: 10.5935/0305-7518.19830026.
6
Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.氯法齐明治疗由耐氨苯砜麻风杆菌引起的瘤型麻风。
Am J Trop Med Hyg. 1972 May;21(3):315-21. doi: 10.4269/ajtmh.1972.21.315.
7
Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.一名正在接受低剂量氨苯砜治疗的患者中出现了耐氨苯砜麻风杆菌。
Int J Lepr Other Mycobact Dis. 1969 Jul-Sep;37(3):296-301.
8
Dapsone-resistant leprosy in a population of Bamako (Mali).马里巴马科人群中的耐氨苯砜麻风病
Lepr Rev. 1980 Dec;51(4):315-9. doi: 10.5935/0305-7518.19800032.
9
Primary dapsone-resistant leprosy.原发性氨苯砜耐药麻风病
Lepr Rev. 1977 Jun;48(2):129-32. doi: 10.5935/0305-7518.19770016.
10
Prevalence of secondary dapsone-resistant leprosy in Upper Volta.
Lepr Rev. 1984 Dec;55(4):361-7. doi: 10.5935/0305-7518.19840041.
Zotero 插件